.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Dow
US Department of Justice
Teva
Express Scripts
Cantor Fitzgerald
McKinsey
Colorcon
Deloitte
Federal Trade Commission

Generated: June 28, 2017

DrugPatentWatch Database Preview

Enalaprilat - Generic Drug Details

« Back to Dashboard

What are the generic sources for enalaprilat and what is the scope of enalaprilat freedom to operate?

Enalaprilat
is the generic ingredient in two branded drugs marketed by Biovail Labs Intl, Athenex Inc, Hospira, Teva Pharms Usa, and Hikma Farmaceutica, and is included in seven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for enalaprilat. Four suppliers are listed for this compound.

Summary for Generic Name: enalaprilat

Tradenames:2
Patents:1
Applicants:5
NDAs:7
Drug Master File Entries: see list8
Suppliers / Packagers: see list4
Bulk Api Vendors: see list37
Clinical Trials: see list7
Patent Applications: see list3,782
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:enalaprilat at DailyMed

Pharmacology for Ingredient: enalaprilat

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
ENALAPRILAT
enalaprilat
INJECTABLE;INJECTION075456-001Aug 22, 2000DISCNNoNo► Subscribe► Subscribe
Hospira
ENALAPRILAT
enalaprilat
INJECTABLE;INJECTION075458-001Aug 22, 2000APRXNoYes► Subscribe► Subscribe
Athenex Inc
ENALAPRILAT
enalaprilat
INJECTABLE;INJECTION075634-001Aug 22, 2000APRXNoYes► Subscribe► Subscribe
Hikma Farmaceutica
ENALAPRILAT
enalaprilat
INJECTABLE;INJECTION078687-001Dec 23, 2008APRXNoNo► Subscribe► Subscribe
Hospira
ENALAPRILAT
enalaprilat
INJECTABLE;INJECTION075571-001Aug 22, 2000DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: enalaprilat

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Biovail Labs Intl
VASOTEC
enalaprilat
INJECTABLE;INJECTION019309-001Feb 9, 19884,374,829*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Deloitte
UBS
Novartis
US Army
Farmers Insurance
Citi
Queensland Health
AstraZeneca
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot